共 169 条
[1]
Bailey CR(2019)Guidelines for day-case surgery 2019: guidelines from the Association of Anaesthetists and the British Association of Day surgery Anaesthesia 74 778-92
[2]
Ahuja M(2021)Propofol maintains Th17/Treg cell balance and reduces inflammation in rats with traumatic brain injury via the miR-145-3p/NFATc2/NFκB axis Int J Mol Med 48 135-70
[3]
Bartholomew K(2010)A phase IIa, randomized, double-blind study of remimazolam (CNS 7056) versus midazolam for sedation in upper gastrointestinal endoscopy J Pain Symptom Manage 40 466-80
[4]
Bew S(2015)Midazolam: a review of therapeutic uses and toxicity Anesth Analg 120 771-65
[5]
Forbes L(1997)Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patients (ASA Class III): results of a multicenter, randomized, double-blind, parallel-group comparative trial J Emerg Med 15 357-501
[6]
Lipp A(2020)Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb/III trial J Anesth 34 491-53
[7]
Cui C(2020)Quality of Recovery after General Anesthesia with Remimazolam in patients’ undergoing urologic surgery: a randomized controlled trial comparing remimazolam with Propofol J Anesth 34 543-209
[8]
Zhang D(2022)A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): part II. Population pharmacokinetic and pharmacodynamic modeling and simulation Drug Des Devel Ther 16 1199-96
[9]
Sun K(2012)Remimazolam tosilate in upper gastrointestinal endoscopy: a multicenter, randomized, non-inferiority, phase III trial Anesth Analg 115 284-81
[10]
Li H(2021)The efficacy and safety of remimazolam tosylate versus propofol in patients undergoing colonoscopy: a multicentered, randomized, positive-controlled, phase III clinical trial J Gastroenterol Hepatol 36 474-603